{"id":"https://openalex.org/W2000673625","doi":"https://doi.org/10.1158/1538-7445.am2013-2221","title":"Abstract 2221: Enhanced SH3:linker interaction allosterically sensitizes Abl kinases to small molecule inhibitors.","display_name":"Abstract 2221: Enhanced SH3:linker interaction allosterically sensitizes Abl kinases to small molecule inhibitors.","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W2000673625","doi":"https://doi.org/10.1158/1538-7445.am2013-2221","mag":"2000673625"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2013-2221","doi":"https://doi.org/10.1158/1538-7445.am2013-2221","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-2221","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077946976","display_name":"Shoghag B. Panjarian","orcid":"https://orcid.org/0000-0003-0861-9767","observed_orcids":["https://orcid.org/0000-0003-0861-9767"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shoghag B. Panjarian","raw_affiliation_strings":["1Univ. of Pittsburgh, Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Pittsburgh, Pittsburgh, PA;","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030245525","display_name":"Roxana E. Iacob","orcid":"https://orcid.org/0000-0001-6106-4698","observed_orcids":["https://orcid.org/0000-0001-6106-4698"]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roxana Iacob","raw_affiliation_strings":["2Northeastern University, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Northeastern University, Boston, MA;","institution_ids":["https://openalex.org/I12912129"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chen Shugui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chen Shugui","raw_affiliation_strings":["3Case Western Reserve University, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071831434","display_name":"Thomas E. Wales","orcid":"https://orcid.org/0000-0001-6133-5689","observed_orcids":["https://orcid.org/0000-0001-6133-5689"]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Wales","raw_affiliation_strings":["2Northeastern University, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Northeastern University, Boston, MA;","institution_ids":["https://openalex.org/I12912129"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082763070","display_name":"John R. Engen","orcid":"https://orcid.org/0000-0002-6918-9476","observed_orcids":["https://orcid.org/0000-0002-6918-9476"]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John R. Engen","raw_affiliation_strings":["2Northeastern University, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Northeastern University, Boston, MA;","institution_ids":["https://openalex.org/I12912129"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051930564","display_name":"Thomas E. Smithgall","orcid":"https://orcid.org/0000-0001-5238-3806","observed_orcids":["https://orcid.org/0000-0001-5238-3806"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas E. Smithgall","raw_affiliation_strings":["1Univ. of Pittsburgh, Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Pittsburgh, Pittsburgh, PA;","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"8_Supplement","first_page":"2221","last_page":"2221"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.016899999231100082,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.9670000076293945},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.9240000247955322},{"id":"https://openalex.org/keywords/c-abl","display_name":"c-Abl","score":0.7200000286102295},{"id":"https://openalex.org/keywords/kinase-domain-conformation","display_name":"kinase domain conformation","score":0.6840000152587891},{"id":"https://openalex.org/keywords/chemical-sensitizers","display_name":"chemical sensitizers","score":0.6050000190734863},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.8790000081062317},{"id":"https://openalex.org/keywords/hydrogen-deuterium-exchange-mass-spectrometry","display_name":"hydrogen-deuterium exchange mass spectrometry","score":0.8090000152587891},{"id":"https://openalex.org/keywords/atp-competitive-inhibitors","display_name":"ATP-competitive inhibitors","score":0.5759999752044678}],"concepts":[{"id":"https://openalex.org/C32619005","wikidata":"https://www.wikidata.org/wiki/Q24768234","display_name":"Protein kinase domain","level":4,"score":0.6305689811706543},{"id":"https://openalex.org/C196347352","wikidata":"https://www.wikidata.org/wiki/Q24771787","display_name":"SH3 domain","level":4,"score":0.5880671739578247},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.5879546403884888},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5802375078201294},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5509119629859924},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.5464348793029785},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.511438250541687},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.45856228470802307},{"id":"https://openalex.org/C150109051","wikidata":"https://www.wikidata.org/wiki/Q3630494","display_name":"Autophosphorylation","level":4,"score":0.44417861104011536},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.4342155158519745},{"id":"https://openalex.org/C197153747","wikidata":"https://www.wikidata.org/wiki/Q24780316","display_name":"SH2 domain","level":4,"score":0.43394726514816284},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.4308611750602722},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36559778451919556},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3584956228733063},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.33898621797561646},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30365821719169617},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.291745662689209},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.21100959181785583},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.11071917414665222},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1044725775718689},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.09856614470481873},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2013-2221","doi":"https://doi.org/10.1158/1538-7445.am2013-2221","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-2221","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.5683000087738037,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1992251850","https://openalex.org/W2324529717","https://openalex.org/W62281569","https://openalex.org/W2979571032","https://openalex.org/W2078135059","https://openalex.org/W1865211688","https://openalex.org/W2057147161","https://openalex.org/W601527880","https://openalex.org/W2245732719","https://openalex.org/W2151724015"],"abstract_inverted_index":{"Abstract":[0],"Bcr-Abl":[1,30,130,158,231,334],"is":[2,35,55,305],"the":[3,9,46,50,61,65,73,76,97,105,116,124,140,167,171,184,188,213,221,239,251,277,280,285,291,308,314,324,338,373,378],"oncogenic":[4],"protein-tyrosine":[5],"kinase":[6,31,51,77,107,135,141,189,339],"responsible":[7],"for":[8,381],"pathogenesis":[10],"of":[11,18,29,49,60,75,96,115,154,170,187,253,259,265,310,333,372,377],"chronic":[12],"myelogenous":[13],"leukemia":[14],"(CML).":[15],"Clinical":[16],"management":[17],"CML":[19],"has":[20],"been":[21],"revolutionized":[22],"by":[23,57,84,199,210],"imatinib,":[24],"a":[25,133,152,200],"selective":[26],"ATP-competitive":[27],"inhibitor":[28,144],"activity.":[32],"Imatinib":[33,79],"selectivity":[34],"due":[36],"in":[37,69,129,212,250,284,307,337],"part":[38],"to":[39,42,64,143,234,238,365],"its":[40],"ability":[41],"recognize":[43],"and":[44,157,206,256,290,312],"stabilize":[45,132],"inactive":[47],"conformation":[48,54,109],"domain.":[52,78,340],"This":[53],"stabilized":[56,178],"intramolecular":[58,179],"binding":[59,91,181,203,215,242,282,288],"SH3":[62,117,180],"domain":[63,108,136,142],"SH2-kinase":[66],"linker,":[67,172],"which":[68],"turn":[70],"packs":[71],"against":[72],"back":[74],"resistance":[80],"can":[81],"be":[82],"caused":[83],"point":[85],"mutations":[86,211],"that":[87,102,122,177,301,316],"either":[88],"affect":[89],"drug":[90,335],"directly":[92],"(e.g.,":[93,110],"through":[94,111],"mutation":[95,112],"gatekeeper":[98],"position,":[99],"Thr315)":[100],"or":[101,113],"allosterically":[103,361],"disturb":[104],"downregulated":[106,134],"phosphorylation":[114],"domain).":[118],"These":[119,246],"observations":[120],"suggest":[121],"strengthening":[123],"regulatory":[125,302,321],"SH3:linker":[126,192,227,278,303,325,359],"interaction":[127,193,228,304,322,360],"present":[128],"may":[131,327],"conformation,":[137],"thus":[138],"sensitizing":[139],"action.":[145],"To":[146],"explore":[147],"this":[148],"possibility,":[149],"we":[150,173],"created":[151],"series":[153],"modified":[155],"c-Abl":[156,196],"proteins":[159,269],"with":[160,270],"enhanced":[161,226],"SH3-linker":[162],"interactions.":[163],"By":[164],"systematically":[165],"increasing":[166],"proline":[168],"content":[169],"identified":[174],"high-affinity":[175,271],"linkers":[176,272],"without":[182],"disturbing":[183],"overall":[185],"regulation":[186],"core.":[190],"Enhanced":[191,358],"completely":[194],"reversed":[195],"core":[197,268],"activation":[198,209],"C-lobe":[201,286],"myristate":[202,287],"pocket":[204,243],"mutation,":[205],"substantially":[207],"reduced":[208],"ATP":[214],"site":[216,283],"(T315I)":[217],"as":[218,220,330],"well":[219],"SH2:C-lobe":[222],"interface":[223,326],"(Y158D).":[224],"Remarkably,":[225],"dramatically":[229],"sensitized":[230],"not":[232],"only":[233],"imatinib":[235],"but":[236],"also":[237],"myristic":[240],"acid":[241],"inhibitor,":[244],"GNF-2.":[245],"effects":[247],"were":[248],"observed":[249],"context":[252,309],"both":[254],"wild-type":[255],"imatinib-resistant":[257],"forms":[258],"Bcr-Abl.":[260],"Hydrogen":[261],"exchange":[262],"mass":[263],"spectrometry":[264],"recombinant":[266],"Abl":[267,363],"revealed":[273],"dynamic":[274],"coupling":[275],"between":[276],"interface,":[279],"GNF-2":[281],"pocket,":[289],"active":[292],"site.":[293],"Taken":[294],"together,":[295],"these":[296],"studies":[297],"provide":[298],"strong":[299],"evidence":[300],"retained":[306],"Bcr-Abl,":[311],"supports":[313],"idea":[315],"small":[317,366],"molecules":[318],"enhancing":[319],"natural":[320],"at":[323],"have":[328],"utility":[329],"chemical":[331],"sensitizers":[332],"action":[336],"Citation":[341],"Format:":[342],"Shoghag":[343],"B.":[344],"Panjarian,":[345],"Roxana":[346],"Iacob,":[347],"Chen":[348],"Shugui,":[349],"Thomas":[350,355],"Wales,":[351],"John":[352],"R.":[353],"Engen,":[354],"E.":[356],"Smithgall.":[357],"sensitizes":[362],"kinases":[364],"molecule":[367],"inhibitors.":[368],"[abstract].":[369],"In:":[370],"Proceedings":[371],"104th":[374],"Annual":[375],"Meeting":[376],"American":[379],"Association":[380],"Cancer":[382,392],"Research;":[383],"2013":[384],"Apr":[385],"6-10;":[386],"Washington,":[387],"DC.":[388],"Philadelphia":[389],"(PA):":[390],"AACR;":[391],"Res":[393],"2013;73(8":[394],"Suppl):Abstract":[395],"nr":[396],"2221.":[397],"doi:10.1158/1538-7445.AM2013-2221":[398]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}